ENT-01 Safe, Improves Constipation in Patients With Parkinson Disease
MONDAY, Nov. 7, 2022 (HealthDay News) — Oral ENT-01, which inhibits the formation of α-synuclein aggregation, is safe and improves constipation among patients with Parkinson disease (PD) and constipation, according to a study published online Nov. 8 …
Learn MoreUn antihipertensivo común podría prevenir el Alzheimer en los pacientes negros
VIERNES, 4 de noviembre de 2022 (HealthDay News) — Un nuevo estudio ha mostrado que el antihipertensivo telmisartán podría ofrecer esperanza como tratamiento para el Alzheimer en los pacientes negros. No mostró el mismo beneficio para las personas bl…
Learn MorePaxlovid Lowers Risk of Long COVID
MONDAY, Nov. 7, 2022 (HealthDay News) — The antiviral pill Paxlovid not only reduces hospitalization and death after catching COVID-19: New research shows it also cuts the chances of long COVID by roughly 25%.The drug, which combines a newer antivira…
Learn MoreAHA: Once-Daily Edoxaban Seems Safe for Pediatric Cardiac Patients
FRIDAY, Nov. 4, 2022 (HealthDay News) — Once-daily edoxaban seems safe and effective for pediatric patients with cardiac disease, according to a study presented at the American Heart Association Scientific Sessions 2022, held from Nov. 5 to 7 in Chic…
Learn MoreDapagliflozin May Be Cost-Effective for Treating CKD
FRIDAY, Nov. 4, 2022 (HealthDay News) — Dapagliflozin seems to be cost-effective in the United Kingdom, Germany, and Spain for patients meeting the eligibility criteria for the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Diseas…
Learn MoreOnce-Weekly Semaglutide Cuts BMI for Teens With Obesity
FRIDAY, Nov. 4, 2022 (HealthDay News) — Once-weekly semaglutide plus lifestyle intervention results in a greater reduction in body mass index (BMI) than lifestyle intervention alone among obese adolescents, according to a study published online Nov. …
Learn MoreCommon Blood Pressure Drug Might Prevent Alzheimer’s in Black Patients
FRIDAY, Nov. 4, 2022 (HealthDay News) — A new study has shown the blood pressure drug telmisartan may offer new hope as an Alzheimer’s treatment in Black patients. It did not show the same benefit in white people.Learning how people from different et…
Learn MoreCVS y Walgreens anuncian acuerdos de 10 mil millones de dólares por los opioides
MIÉRCOLES, 2 de noviembre de 2022 (HealthDay News) — Años de litigio sobre la epidemia de opioides podrían acabar pronto: dos cadenas nacionales de farmacias, CVS y Walgreens, anunciaron el miércoles que cada compañía ha aceptado un acuerdo de casi 5…
Learn MoreBrentuximab Vedotin + Chemo Ups Event-Free Survival in Peds Hodgkin Lymphoma
THURSDAY, Nov. 3, 2022 (HealthDay News) — For children with high-risk Hodgkin lymphoma, the addition of brentuximab vedotin to standard chemotherapy results in improved three-year event-free survival, with no increase in toxic effects, according to a…
Learn MoreTelehealth Tied to Higher Buprenorphine Retention
WEDNESDAY, Nov. 2, 2022 (HealthDay News) — Among Veterans Health Administration patients receiving buprenorphine for opioid use disorder (OUD), telehealth is associated with increased retention for both new and continuing patients, according to a stu…
Learn More